A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII

20Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Mutations of the epidermal growth factor receptor (EGFR) are a possible molecular target for cancer therapy. EGFR is frequently amplified in glioblastomas and 30 to 40% of glioblastomas also express the deletion mutation EGFRvIII. This frequent oncogenic mutation provides an opportunity for identifying new anti-glioblastoma therapies. In this study, we sought small molecule inhibitors specific for cancer cells expressing EGFRvIII, using isogenic parental cells without EGFRvIII as a control. Results: A screen of the NCI small molecule diversity set identified one compound, NSC-154829, which consistently inhibited growth of different human glioblastoma cells expressing EGFRvIII, but permitted normal growth of matched control cells. NSC-154829 had no previously established medicinal use, but has a purine-like structural component. Further experiments showed this compound increased apoptosis in cells with EGFRvIII, and moderately affected the expression of p21, independent of any changes in p53 levels or in Akt phosphorylation. Conclusion: These initial results suggest that NSC-154829 or a closely related structure might be further investigated for its potential as an anti-glioblastoma drug, although its precise molecular mechanism is still undefined. © 2007 Trembath et al; licensee BioMed Central Ltd.

Figures

  • Table 1: IC50data for NSC-154829

Cited by Powered by Scopus

313Citations
263Readers
Get full text

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Trembath, D. G., Lal, A., Kroll, D. J., Oberlies, N. H., & Riggins, G. J. (2007). A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII. Molecular Cancer, 6. https://doi.org/10.1186/1476-4598-6-30

Readers over time

‘09‘11‘13‘14‘15‘16‘17‘18‘19‘20‘21‘23036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

40%

Researcher 8

40%

Professor / Associate Prof. 4

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

36%

Agricultural and Biological Sciences 7

32%

Chemistry 4

18%

Biochemistry, Genetics and Molecular Bi... 3

14%

Save time finding and organizing research with Mendeley

Sign up for free
0